Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000284490 refers to the **acyl-CoA synthetase bubblegum family member 2 (ACSBG2) pseudogene**, which is a genomic DNA sequence similar to the functional ACSBG2 gene but is classified as a pseudogene, meaning it does not code for a functional protein product[1][2]. Functional ACSBG2 enzymes are involved in fatty acid metabolism, but as a pseudogene, ENSG00000284490 is not expressed as a protein and does not perform the enzymatic or regulatory functions of active metabolic targets. There is no evidence suggesting that this pseudogene is a therapeutic target, nor is it implicated in disease, drug response, or biomarker roles[1][2]. **Key clarifications:** - This entry is a **pseudogene** and not a protein-coding gene or functional target[2]. - No biological activities, molecular functions, disease roles, or drug interactions are associated with this pseudogene[2]. - The canonical abbreviation "ACSBG2" properly refers to the functional enzyme, not the pseudogene. For the pseudogene, no widely accepted abbreviation is in use[1][2]. - Recording as a target molecule is **incorrect** for any therapeutic or drug discovery context[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Acyl-CoA synthetase bubblegum family member 2 pseudogene.